Article Information
History
- January 22, 2024.
Article Versions
- Version 1 (November 8, 2023 - 09:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rafael Lopes1,*,
- Kien Pham1,
- Fayette Klaassen2,
- Melanie H. Chitwood1,
- Anne M. Hahn1,
- Seth Redmond1,
- Nicole A. Swartwood2,
- Joshua A. Salomon3,
- Nicolas A. Menzies2,
- Ted Cohen1,*,† and
- Nathan D. Grubaugh1,4,*,†
- 1Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, USA
- 2Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA, USA
- 3Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA
- 4Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA
- ↵*Corresponding authors: rafael.lopes{at}yale.edu, theodore.cohen{at}yale.edu, nathan.grubaugh{at}yale.edu
Posted January 22, 2024.
Combining genomic data and infection estimates to characterize the complex dynamics of SARS-CoV-2 Omicron variants in the United States
